You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

Litigation Details for Intercept Pharmaceuticals, Inc. v. MSN Laboratories Private Limited (D. Del. 2020)

✉ Email this page to a colleague

« Back to Dashboard

Intercept Pharmaceuticals, Inc. v. MSN Laboratories Private Limited (D. Del. 2020)

Docket	⤷ Sign Up	Date Filed	2020-09-10
Court	District Court, D. Delaware	Date Terminated	2023-02-24
Cause	35:271 Patent Infringement	Assigned To	Maryellen Noreika
Jury Demand	None	Referred To
Patents	10,047,117; 10,052,337; 10,174,073; 7,138,390; 9,238,673
Link to Docket	External link to docket

Small Molecule Drugs cited in Intercept Pharmaceuticals, Inc. v. MSN Laboratories Private Limited

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Details for Intercept Pharmaceuticals, Inc. v. MSN Laboratories Private Limited (D. Del. 2020)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2020-11-11	14	SO ORDERED	Stipulation to Substitute U.S. Patent No. RE48,286 for U.S. Patent No. 7,138,390 and to Amend the Case Caption… 24 February 2023 1:20-cv-01214 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2020-12-29	21	Complaint - Amended	589 RE286 Patent”);1 9,238,673 (filed June 17, 2013) (“the ’673 Patent”); 10,047,117 (filed Nov. 20…073 Patent”); and 10,758,549 (filed Feb. 11, 2020) (“the ’549 Patent”) (collectively the “patents-in-… 1 The RE286 Patent is a reissue of U.S. Patent No. 7,138,390 (“the ’390 Patent”), which was originally…expiration of patents listed in the Orange Book for OCALIVA®, the ’549 Patent and the RE286 Patent. Hence, …1. This action for patent infringement, brought pursuant to the patent laws of the United States	External link to document
2020-12-29	22	Patent/Trademark Report to Commissioner of Patents	Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,238,673; 10,047,117; 10,052,337; …10 September 2020 1:20-cv-01214 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2020-09-10	4	Patent/Trademark Report to Commissioner of Patents	Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,238,673 B2 ;10,047,117 B2 ;10,052,…10 September 2020 1:20-cv-01214 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.